Showing results (1-10 of 120) with videos related to
Sort By:
Pageof 12
Expert Opinion on Pharmacotherapy|March 19, 2008
Combined anti-proliferative and anti-angiogenic strategies for cancerJair Bar, Amir OnnClinical Lung Cancer|December 14, 2011
Overcoming molecular mechanisms of resistance to first-generation epidermal growth factor receptor tyrosine kinase inhibitorsJair Bar, Amir OnnJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 7, 2012
Tumor vasculature as a therapeutic target in non-small cell lung cancerJair Bar, Glenwood D GossSeminars in Cell & Developmental Biology|November 17, 2009
Involvement of stromal p53 in tumor-stroma interactionsJair Bar, Neta Moskovits, Moshe OrenClinical Lung Cancer|May 8, 2009
Multitargeted inhibitors in lung cancer: new clinical dataJair Bar, Roy S Herbst, Amir OnnExpert Opinion on Drug Delivery|August 12, 2009
Targeted drug delivery strategies to treat lung metastasisJair Bar, Roy S Herbst, Amir OnnJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 23, 2013
Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancerDamien Urban, Jair Bar, Benjamin Solomon, et al.Oncogene|February 3, 2004
Attenuation of the p53 response to DNA damage by high cell densityJair Bar, Efrat Cohen-Noyman, Benjamin Geiger, et al.Cancer Research|November 17, 2006
p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblastsNeta Moskovits, Alexander Kalinkovich, Jair Bar, et al.Lung Cancer (Amsterdam, Netherlands)|September 10, 2022
Real-world evidence for immunotherapy in the first line setting in small cell lung cancerShira Sagie, Nitzan Maixner, Amos Stemmer, et al.Pageof 12